Cristine Delnevo, a professor in the Department of Health Behavior, Society and Policy, has been appointed chairperson of a committee under the U.S. Food and Drug Administration (FDA), according to an article from Patch.
Delnevo is also the director of the Rutgers Center for Tobacco Studies and was appointed to the Tobacco Products Scientific Advisory Committee based on her expertise in evaluating tobacco products.
The committee analyzes safety and health information for tobacco products and provides recommendations and advice to the FDA’s commissioner, according to the article. Delnevo will remain chair until 2025.
"I have valued the importance of this FDA advisory committee since the signing of the Family Smoking Prevention and Tobacco Control Act in 2009," she said. "I look forward to working with an esteemed group of colleagues to help the FDA make regulatory decisions to protect public health and reduce tobacco-related morbidity and mortality."
Delnevo's background in the field spans tobacco control policy and regulation and analyzing tobacco behavior trends on a population level, especially regarding the use of cigars and e-cigarettes, according to the article. She has also written more than 250 scientific articles.
Brian Strom, chancellor of Rutgers Biomedical and Health Sciences, expressed his excitement and support for Delnevo’s appointment.
"I am confident that Dr. Delnevo will bring to this role her passion, commitment, and leadership skills, which she has already exhibited at the Rutgers Center for Tobacco Studies, and will help FDA make decisions for the country that will help save lives,” he said.